A citation-based method for searching scientific literature

Jada G Hamilton, Elyse Shuk, Margaux C Genoff, Vivian M Rodríguez, Jennifer L Hay, Kenneth Offit, Mark E Robson. J Oncol Pract 2017
Times Cited: 11







List of co-cited articles
34 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet. Med. 2017
592
45

Attitudes of patients with cancer about personalized medicine and somatic genetic testing.
Stacy W Gray, Katherine Hicks-Courant, Christopher S Lathan, Levi Garraway, Elyse R Park, Jane C Weeks. J Oncol Pract 2012
63
45

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
Fiona A Miller, Robin Z Hayeems, Jessica P Bytautas, Philippe L Bedard, Scott Ernst, Hal Hirte, Sebastien Hotte, Amit Oza, Albiruni Razak, Stephen Welch,[...]. Eur. J. Hum. Genet. 2014
56
36

Patient preferences regarding incidental genomic findings discovered during tumor profiling.
Melinda L Yushak, Gang Han, Sara Bouberhan, Lianne Epstein, Michael P DiGiovanna, Sarah S Mougalian, Tara B Sanft, Maysa M Abu-Khalaf, Gina G Chung, Stacey M Stein,[...]. Cancer 2016
24
27

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Diana Mandelker, Liying Zhang, Yelena Kemel, Zsofia K Stadler, Vijai Joseph, Ahmet Zehir, Nisha Pradhan, Angela Arnold, Michael F Walsh, Yirong Li,[...]. JAMA 2017
135
27

The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing results.
Yvonne Bombard, Marc Clausen, Chloe Mighton, Lindsay Carlsson, Selina Casalino, Emily Glogowski, Kasmintan Schrader, Michael Evans, Adena Scheer, Nancy Baxter,[...]. Eur. J. Hum. Genet. 2018
10
30


Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
Ahmet Zehir, Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R Kim, Preethi Srinivasan, Jianjiong Gao, Debyani Chakravarty, Sean M Devlin,[...]. Nat. Med. 2017
873
18

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J. Clin. Oncol. 2015
234
18

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
Douglas E Levy, Stacey D Byfield, Catherine B Comstock, Judy E Garber, Sapna Syngal, William H Crown, Alexandra E Shields. Genet. Med. 2011
141
18

Disparities in genetic testing: thinking outside the BRCA box.
Michael J Hall, Olufunmilayo I Olopade. J. Clin. Oncol. 2006
98
18

Communication of BRCA results and family testing in 1,103 high-risk women.
Eleanor L Cheung, Ashley D Olson, Tina M Yu, Pamela Z Han, Mary S Beattie. Cancer Epidemiol. Biomarkers Prev. 2010
44
18

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Colin C Pritchard, Joaquin Mateo, Michael F Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind Eeles,[...]. N. Engl. J. Med. 2016
470
18

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.
Donavan T Cheng, Talia N Mitchell, Ahmet Zehir, Ronak H Shah, Ryma Benayed, Aijazuddin Syed, Raghu Chandramohan, Zhen Yu Liu, Helen H Won, Sasinya N Scott,[...]. J Mol Diagn 2015
678
18

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
Kasmintan A Schrader, Donavan T Cheng, Vijai Joseph, Meera Prasad, Michael Walsh, Ahmet Zehir, Ai Ni, Tinu Thomas, Ryma Benayed, Asad Ashraf,[...]. JAMA Oncol 2016
126
18

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet. Med. 2013
18

Attitudes toward molecular testing for personalized cancer therapy.
Rafeek A Yusuf, Deevakar Rogith, Shelly R A Hovick, Susan K Peterson, Allison M Burton-Chase, Bryan M Fellman, Yisheng Li, Carolyn McKinney, Elmer V Bernstam, Funda Meric-Bernstam. Cancer 2015
32
18

Additional germline findings from a tumor profiling program.
Neda Stjepanovic, Tracy L Stockley, Philippe L Bedard, Jeanna M McCuaig, Melyssa Aronson, Spring Holter, Kara Semotiuk, Natasha B Leighl, Raymond Jang, Monika K Krzyzanowska,[...]. BMC Med Genomics 2018
5
40

Next-generation sequencing in precision oncology: Patient understanding and expectations.
J Scott Roberts, Michele C Gornick, Lan Q Le, Natalie J Bartnik, Brian J Zikmund-Fisher, Arul M Chinnaiyan. Cancer Med 2019
8
25

Patients' perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project.
Philip J Lupo, Jill O Robinson, Pamela M Diamond, Leila Jamal, Heather E Danysh, Jennifer Blumenthal-Barby, Lisa Soleymani Lehmann, Jason L Vassy, Kurt D Christensen, Robert C Green,[...]. Per Med 2016
16
18

Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing.
Layla Shahmirzadi, Elizabeth C Chao, Erika Palmaer, Melissa C Parra, Sha Tang, Kelly D Farwell Gonzalez. Genet. Med. 2014
63
18

Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial.
Salma Shickh, Marc Clausen, Chloe Mighton, Selina Casalino, Esha Joshi, Emily Glogowski, Kasmintan A Schrader, Adena Scheer, Christine Elser, Seema Panchal,[...]. BMJ Open 2018
12
18


Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.
D Williams Parsons, Angshumoy Roy, Yaping Yang, Tao Wang, Sarah Scollon, Katie Bergstrom, Robin A Kerstein, Stephanie Gutierrez, Andrea K Petersen, Abhishek Bavle,[...]. JAMA Oncol 2016
168
18

Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment.
Dean A Regier, Stuart J Peacock, Reka Pataky, Kimberly van der Hoek, Gail P Jarvik, Jeffrey Hoch, David Veenstra. CMAJ 2015
40
18


Translating genomics in cancer care.
Yvonne Bombard, Peter B Bach, Kenneth Offit. J Natl Compr Canc Netw 2013
42
18

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet. Med. 2015
18

Genomic testing in cancer: patient knowledge, attitudes, and expectations.
Phillip S Blanchette, Anna Spreafico, Fiona A Miller, Kelvin Chan, Jessica Bytautas, Steve Kang, Philippe L Bedard, Andrea Eisen, Larissa Potanina, Jack Holland,[...]. Cancer 2014
38
18

A new initiative on precision medicine.
Francis S Collins, Harold Varmus. N Engl J Med 2015
18

Recommendations for returning genomic incidental findings? We need to talk!
Wylie Burke, Armand H Matheny Antommaria, Robin Bennett, Jeffrey Botkin, Ellen Wright Clayton, Gail E Henderson, Ingrid A Holm, Gail P Jarvik, Muin J Khoury, Bartha Maria Knoppers,[...]. Genet. Med. 2013
191
18

Preferences for return of incidental findings from genome sequencing among women diagnosed with breast cancer at a young age.
K A Kaphingst, J Ivanovich, B B Biesecker, R Dresser, J Seo, L G Dressler, P J Goodfellow, M S Goodman. Clin. Genet. 2016
21
18

Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.
Stacy W Gray, Elyse R Park, Julie Najita, Yolanda Martins, Lara Traeger, Elizabeth Bair, Joshua Gagne, Judy Garber, Pasi A Jänne, Neal Lindeman,[...]. Genet. Med. 2016
48
18

A Model for Genome-First Care: Returning Secondary Genomic Findings to Participants and Their Healthcare Providers in a Large Research Cohort.
Marci L B Schwartz, Cara Zayac McCormick, Amanda L Lazzeri, D'Andra M Lindbuchler, Miranda L G Hallquist, Kandamurugu Manickam, Adam H Buchanan, Alanna Kulchak Rahm, Monica A Giovanni, Lauren Frisbie,[...]. Am. J. Hum. Genet. 2018
36
18


Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy.
Talal Hilal, Mary Nakazawa, Jacob Hodskins, John L Villano, Aju Mathew, Guarav Goel, Lars Wagner, Susanne M Arnold, Philip DeSimone, Lowell B Anthony,[...]. BMC Cancer 2017
6
16

Advanced cancer patients' attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study.
R Liang, B Meiser, S Smith, N A Kasparian, C R Lewis, M Chin, G V Long, R Ward, A M Menzies, J N Harris-Wai,[...]. Eur J Cancer Care (Engl) 2017
8
12



Ethical frameworks for obtaining informed consent in tumour profiling: an evidence-based case for Singapore.
Yasmin Bylstra, Tamra Lysaght, Jyothi Thrivikraman, Sangeetha Watson, Patrick Tan. Hum. Genomics 2017
4
25

Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non-Small Cell Lung Cancer in the Community Oncology Setting.
Carolyn J Presley, Daiwei Tang, Pamela R Soulos, Anne C Chiang, Janina A Longtine, Kerin B Adelson, Roy S Herbst, Weiwei Zhu, Nathan C Nussbaum, Rachael A Sorg,[...]. JAMA 2018
38
9

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.
Elena Castro, Chee Goh, David Olmos, Ed Saunders, Daniel Leongamornlert, Malgorzata Tymrakiewicz, Nadiya Mahmud, Tokhir Dadaev, Koveela Govindasami, Michelle Guy,[...]. J. Clin. Oncol. 2013
285
9

Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.
Emmanuel S Antonarakis, Changxue Lu, Brandon Luber, Chao Liang, Hao Wang, Yan Chen, John L Silberstein, Danilo Piana, Zhao Lai, Yidong Chen,[...]. Eur. Urol. 2018
56
9

Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter?
Kelvin A Moses, Heather Orom, Alicia Brasel, Jacquelyne Gaddy, Willie Underwood. Urology 2017
22
9

A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic Counseling.
Heather H Cheng, Nola Klemfuss, Bruce Montgomery, Celestia S Higano, Michael T Schweizer, Elahe A Mostaghel, Lisa G McFerrin, Evan Y Yu, Peter S Nelson, Colin C Pritchard. Prostate 2016
13
9

Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer.
Heather Hampel, Rachel Pearlman, Mallory Beightol, Weiqiang Zhao, Daniel Jones, Wendy L Frankel, Paul J Goodfellow, Ahmet Yilmaz, Kristin Miller, Jason Bacher,[...]. JAMA Oncol 2018
52
9

Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.
Renea A Taylor, Michael Fraser, Julie Livingstone, Shadrielle Melijah G Espiritu, Heather Thorne, Vincent Huang, Winnie Lo, Yu-Jia Shiah, Takafumi N Yamaguchi, Ania Sliwinski,[...]. Nat Commun 2017
75
9


Prognostic and therapeutic implications of DNA repair gene mutations in advanced prostate cancer.
Michael T Schweizer, Emmanuel S Antonarakis. Clin Adv Hematol Oncol 2017
12
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.